Sudarshan Pharma Industries Ltd — Results, 24-04-2025: Result

Sudarshan Pharma Industries has reported its audited standalone financial results for the half-year and year ended March 31, 2025. The company generated a total income of ₹46,837.37 crore, with a net profit of ₹1,135.53 crore. Total expenses amounted to ₹45,327.56 crore, leading to a profit before tax of ₹1,509.81 crore. The total assets of the company as of the end of this financial year are ₹40,240.84 crore, with equity reserve exceeding ₹10,359 crore.

The company's performance showcases significant growth and operational strength. Additionally, it recently acquired 100% of a subsidiary in Singapore and 51% of another in India, suggesting a strategic focus on expansion. Despite challenges, such as operational disruptions due to heavy rainfall, the financial outlook appears robust, presenting both opportunities for growth while also carrying some operational risks.